MUCIN PROFILE OF PROSTATIC LESIONS: A HISTOCHEMICAL APPROACH FOR DIFFERENTIATION IN A TERTIARY CARE CENTER.
DOI:
https://doi.org/10.51168/sjhrafrica.v6i3.1713Keywords:
Prostate, Mucin, PAS, Alcian Blue, Mucicarmine, Histochemistry, Benign Prostatic Hyperplasia, AdenocarcinomaAbstract
Background: Microscopic differentiation of benign and low grade malignant lesions of prostate pose a challenging task for the pathologists. Immunohistochemistry markers can prove costlier in resource poor settings.
Objectives : To assess the utility of mucin stains in evaluating and differentiating benign and malignant lesions of prostate.
Materials and Methods : 100 prostatic biopsies received in the Pathology department of atertiary care hospital over a period of one and half years were included in this study. In additiontoroutineH&E,thesectionswerestainedwithPeriodicacidSchiff (PAS),Alcianblue(AB) andMucicarmine(MC) stains.
Results: Out of 100 prostatic biopsies studied, 90% of benign cases and 53% malignant lesions showed positivity with Periodic acid Schiff (PAS) stain. With Alcian blue, 67% of malignant lesions showed positivity and with Mucicarmine 60% of malignant lesions showed positivity. In contrast only 1% of benign lesions were positive with Alcian blue and Mucicarmine
Conclusions: Neutral mucin was found to be more frequently positive in benign lesions of prostate whereas acidic mucin is expressed only in malignant lesions
References
Arora VK, et al. Histochemical staining in prostate carcinoma. Indian J Pathol Microbiol. 2005.
Agarwal PK, et al. Role of mucin stains in prostate cancer. J Clin Diagn Res. 2012.
McMahon RF, et al. Mucin expression in prostatic tissues. Histopathology. 1990.
Pinder SE, et al. Acidic mucins in prostatic neoplasia. J Pathol. 1995.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Srikanth.K, Dr. Vijay David Raj, Dr. Natarajan Suresh, Dr. Mourouguessine Vimal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.